PET study on striatal dopamine D<sub>2</sub> receptor changes during the progression of early parkinson's disease

DOI Web Site Web Site 被引用文献6件

抄録

<jats:title>Abstract</jats:title><jats:p>[<jats:sup>11</jats:sup>C] Raclopride uptake to dopamine D<jats:sub>2</jats:sub> receptors was investigated with positron emission tomography (PET) in patients with early Parkinson's disease at the time of the diagnosis and after a half‐year interval. During this progressive period of the disease, the patients received no antiparkinsonian medication. The upregulation of striatal D<jats:sub>2</jats:sub> receptors, which was seen in all patients already at the time of the diagnosis, persisted. Although the patients initially showed unilateral disease, they had developed bilateral symptoms by the time of the second PET scan, but the disease was still asymmetric. The present results show that the relative increase in [<jats:sup>11</jats:sup>C]raclopride uptake in the striatum contralateral to the symptoms as compared with the opposite striatum will be preserved even during the progression of the disease, provided that the symptoms show clear‐cut asymmetry.</jats:p>

収録刊行物

被引用文献 (6)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ